Our results confirm the important role of Mala s 11 in patients suffering from a moderate and severe form of AD; in these patients, a very high level of specific IgE (class 4) to Mala s 11 was recorded in 36% of patients and a moderate level of specific IgE (class 2) was recorded in 16% of patients. This evidence concerns the gene IGHE and Alzheimer disease.